Keyphrases
Parkinson's Disease
100%
Leucine-rich Repeat Kinase 2 (LRRK2)
81%
Rab10
25%
Phosphorylation
23%
Idiopathic Parkinson's Disease
23%
VPS35
17%
Kinase Cascade
16%
Disease-modifying Therapy
14%
Clinical Trials
14%
Peripheral Blood Neutrophils
11%
Dementia with Lewy Bodies
11%
Brain Cells
11%
Human Peripheral Blood
11%
Mitochondrial DNA Damage
10%
Bisphosphonates
10%
Genetic Screening
10%
Early-onset Dementia
10%
Austrian
10%
New Disease
10%
Dementia Patients
10%
Mutation Carriers
9%
R1441C
9%
Patient Stratification
9%
Protein Phosphorylation
8%
Parkinson's Disease Dementia
7%
Kinase Activity
7%
Pathway Activity
7%
Single-arm Trial
7%
Parkinson Patients
7%
Parkinson
7%
Molecular Mechanism
6%
Pathogenic Variants
6%
Penetrance
6%
Peripheral Blood
6%
Targeted Mass Spectrometry
6%
Sortilin-related Receptor
6%
Receptor 1
6%
Human Neutrophils
6%
Multiplexing
6%
Activation Status
6%
Multi-arm multi-stage
6%
Platform Trials
6%
GBA Gene
5%
G2019S mutation
5%
Rab Proteins
5%
Disease-associated
5%
Orally Bioavailable
5%
Vesicle Trafficking Pathways
5%
Lewy Bodies
5%
Human Peripheral Blood Monocytes
5%
Biochemistry, Genetics and Molecular Biology
Kinase
60%
Phosphotransferase
60%
Leucine-Rich Repeat
55%
Genetics
32%
LRRK2
29%
Clinical Trial
26%
VPS35
16%
Genetic Screening
15%
Neutrophil Granulocyte
14%
Mass Spectrometry
11%
Protein Phosphorylation
10%
DNA Damage
10%
Mitochondrial DNA
10%
Penetrance
9%
TREM2
7%
Transgenic Mouse
6%
Stoichiometry
5%
Genetic Trait
5%
Recombinant
5%
Solution and Solubility
5%
Protein Catabolism
5%
Allele
5%
Whole Genome Sequencing
5%
Human Genomics
5%
Pseudogene
5%
Stereotypy
5%
Blood Brain Barrier
5%
Social Interaction
5%
Lipoprotein
5%
Lipoprotein Receptor-Related Protein
5%
Clinical Research
5%
Ubiquitination
5%
Electrical Synapse
5%
Neuroligin
5%
Isoform
5%
C-Terminus
5%
Gap Junction Protein
5%
Phospholipid
5%
Genetic Test
5%
Protein Homeostasis
5%
Proteome
5%